TY - JOUR
T1 - Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade
AU - Da Silva, Ines Pires
AU - Gallois, Anne
AU - Jimenez-Baranda, Sonia
AU - Khan, Shaukat
AU - Anderson, Ana C.
AU - Kuchroo, Vijay K.
AU - Osman, Iman
AU - Bhardwaj, Nina
N1 - Publisher Copyright:
© 2014 American Association for Cancer Research.
PY - 2014/5
Y1 - 2014/5
N2 - The immunoregulatory protein T-cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates T-cell exhaustion and contributes to the suppression of immune responses in both viral infections and tumors. Tim-3 blockade reverses the exhausted phenotype of CD4+ and CD8+ T cells in several chronic diseases, including melanoma. Interestingly, natural killer (NK) cells constitutively express Tim-3; however, the role of Tim-3 in modulating the function of these innate effector cells remains unclear, particularly in human diseases. In this study, we compared the function of Tim-3 in NK cells from healthy donors and patients with metastatic melanoma. NK cells from the latter were functionally impaired/exhausted, and Tim-3 blockade reversed this exhausted phenotype. Moreover, Tim-3 expression levels were correlated with the stage of the disease and poor prognostic factors. These data indicate that Tim-3 can function as an NK-cell exhaustion marker in advanced melanoma and support the development of Tim-3-targeted therapies to restore antitumor immunity.
AB - The immunoregulatory protein T-cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates T-cell exhaustion and contributes to the suppression of immune responses in both viral infections and tumors. Tim-3 blockade reverses the exhausted phenotype of CD4+ and CD8+ T cells in several chronic diseases, including melanoma. Interestingly, natural killer (NK) cells constitutively express Tim-3; however, the role of Tim-3 in modulating the function of these innate effector cells remains unclear, particularly in human diseases. In this study, we compared the function of Tim-3 in NK cells from healthy donors and patients with metastatic melanoma. NK cells from the latter were functionally impaired/exhausted, and Tim-3 blockade reversed this exhausted phenotype. Moreover, Tim-3 expression levels were correlated with the stage of the disease and poor prognostic factors. These data indicate that Tim-3 can function as an NK-cell exhaustion marker in advanced melanoma and support the development of Tim-3-targeted therapies to restore antitumor immunity.
UR - https://www.scopus.com/pages/publications/84908397938
U2 - 10.1158/2326-6066.CIR-13-0171
DO - 10.1158/2326-6066.CIR-13-0171
M3 - Article
C2 - 24795354
AN - SCOPUS:84908397938
SN - 2326-6066
VL - 2
SP - 410
EP - 422
JO - Cancer Immunology Research
JF - Cancer Immunology Research
IS - 5
ER -